Medullary Thyroid Carcinoma: The Third Most Common Thyroid Cancer Reviewed

Overview

Journal Oncol Lett

Specialty Oncology

Date 2012 Aug 8

PMID 22870127

Citations 13

Authors

Michael Stamatakos

Panoraia Paraskeva

Charikleia Stefanaki

Paraskevas Katsaronis

Andreas Lazaris

Konstantinos Safioleas

Konstantinos Kontzoglou

Affiliations

Soon will be listed here.

Abstract

Medullary thyroid cancer is a type of thyroid cancer of neuroendocrine origin. It occurs in hereditary and sporadic forms, and its aggressive behavior is associated with the clinical presentation and type of RET mutation. Total thyroidectomy remains the ideal choice of treatment. Early diagnosis and treatment are the fundamental for a 100% cure rate. In this study, we present our experience of 3 cases, along with a complete review of the literature derived from a Pubmed Database search.

Citing Articles

The Efficacy and Safety of Anlotinib in the Treatment of Thyroid Cancer: A Systematic Review.

Muntean C, Solomon A, Cipaian R, Vonica R, Butuca A, Gaborean V J Clin Med. 2025; 14(2.

PMID: 39860342 PMC: 11765571. DOI: 10.3390/jcm14020338.

A novel role for nonactin: interfering with G-quadruplex in RET-driven medullary thyroid cancer.

Alqahtani T, Alsubait A, Aloumi M, Alamer A, Alomari G, Alwassil O BMC Cancer. 2024; 24(1):1569.

PMID: 39716145 PMC: 11665027. DOI: 10.1186/s12885-024-13345-9.

Limited Thyroidectomy Achieves Equivalent Survival to Total Thyroidectomy for Early Localized Medullary Thyroid Cancer.

Jishu J, Hussein M, Sadakkadulla S, Baah S, Bashumeel Y, Toraih E Cancers (Basel). 2024; 16(23).

PMID: 39682246 PMC: 11640154. DOI: 10.3390/cancers16234062.

Non-secretory medullary thyroid carcinoma with laryngotracheal invasion: a case report and review of the literature.

Alsalamah S, Althunayan T, Alaraifi A, Alessa M AME Case Rep. 2024; 8:87.

PMID: 39380863 PMC: 11459395. DOI: 10.21037/acr-24-45.

LINC00887 Acts as an Enhancer RNA to Promote Medullary Thyroid Carcinoma Progression by Binding with FOXQ1.

Liu D, Wang W, Wu Y, Qiu Y, Zhang L Curr Cancer Drug Targets. 2024; 24(5):519-533.

PMID: 38804344 DOI: 10.2174/0115680096258716231026063704.

References

Cohen M, Hussain H, Moley J . Inhibition of medullary thyroid carcinoma cell proliferation and RET phosphorylation by tyrosine kinase inhibitors. Surgery. 2002; 132(6):960-6; discussion 966-7. DOI: 10.1067/msy.2002.128562. View

Rufini V, Castaldi P, Treglia G, Perotti G, Gross M, Al-Nahhas A . Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma. Biomed Pharmacother. 2007; 62(3):139-46. DOI: 10.1016/j.biopha.2007.07.011. View

Bhattacharyya N . A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma. Otolaryngol Head Neck Surg. 2003; 128(1):115-23. DOI: 10.1067/mhn.2003.2. View

Toledo S, Lourenco Jr D, Santos M, Tavares M, Toledo R, Correia-Deur J . Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma. Clinics (Sao Paulo). 2009; 64(7):699-706. PMC: 2710445. DOI: 10.1590/S1807-59322009000700015. View

Clark J, Fridman T, Odell M, Brierley J, Walfish P, Freeman J . Prognostic variables and calcitonin in medullary thyroid cancer. Laryngoscope. 2005; 115(8):1445-50. DOI: 10.1097/01.mlg.0000168114.90852.a6. View

Schlumberger M, Carlomagno F, Baudin E, Bidart J, Santoro M . New therapeutic approaches to treat medullary thyroid carcinoma. Nat Clin Pract Endocrinol Metab. 2007; 4(1):22-32. DOI: 10.1038/ncpendmet0717. View

Matoso A, Zhou Z, Hayama R, Flesken-Nikitin A, Nikitin A . Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia. Carcinogenesis. 2007; 29(3):620-8. DOI: 10.1093/carcin/bgm207. View

Fialkowski E, Moley J . Current approaches to medullary thyroid carcinoma, sporadic and familial. J Surg Oncol. 2006; 94(8):737-47. DOI: 10.1002/jso.20690. View

Boikos S, Stratakis C . Molecular mechanisms of medullary thyroid carcinoma: current approaches in diagnosis and treatment. Histol Histopathol. 2007; 23(1):109-16. DOI: 10.14670/HH-23.109. View

10.

Liu F, Hsueh C, Chang H, Liou M, Huang B, Lin J . Sonography and fine-needle aspiration biopsy in the diagnosis of benign versus malignant nodules in patients with autoimmune thyroiditis. J Clin Ultrasound. 2009; 37(9):487-92. DOI: 10.1002/jcu.20633. View

11.

Roman S, Lin R, Sosa J . Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer. 2006; 107(9):2134-42. DOI: 10.1002/cncr.22244. View

12.

Evans D, Burgess M, Goepfert H, Gagel R . Medullary thyroid carcinoma. Curr Ther Endocrinol Metab. 1997; 6:127-32. View

13.

Al-Rawi M, Wheeler M . Medullary thyroid carcinoma--update and present management controversies. Ann R Coll Surg Engl. 2006; 88(5):433-8. PMC: 1964684. DOI: 10.1308/003588406X117043. View

14.

Dralle H, Machens A . Surgical approaches in thyroid cancer and lymph-node metastases. Best Pract Res Clin Endocrinol Metab. 2008; 22(6):971-87. DOI: 10.1016/j.beem.2008.09.018. View

15.

DeLellis R . Pathology and genetics of thyroid carcinoma. J Surg Oncol. 2006; 94(8):662-9. DOI: 10.1002/jso.20700. View

16.

Machens A, Schneyer U, Holzhausen H, Dralle H . Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab. 2005; 90(4):2029-34. DOI: 10.1210/jc.2004-1836. View

17.

Modigliani E, Vasen H, Raue K, Dralle H, Frilling A, Gheri R . Pheochromocytoma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group. J Intern Med. 1995; 238(4):363-7. DOI: 10.1111/j.1365-2796.1995.tb01211.x. View

18.

You Y, Lakhani V, Wells Jr S, Moley J . Medullary thyroid cancer. Surg Oncol Clin N Am. 2006; 15(3):639-60. DOI: 10.1016/j.soc.2006.05.008. View

19.

Ihre Lundgren C, Delbridg L, Learoyd D, Robinson B . Surgical approach to medullary thyroid cancer. Arq Bras Endocrinol Metabol. 2007; 51(5):818-24. DOI: 10.1590/s0004-27302007000500020. View

20.

Bergholm U, Bergstrom R, Ekbom A . Long-term follow-up of patients with medullary carcinoma of the thyroid. Cancer. 1997; 79(1):132-8. DOI: 10.1002/(sici)1097-0142(19970101)79:1<132::aid-cncr19>3.0.co;2-5. View